Latest filing published 31 Jul 2026 for 富士製薬工業株式会社, €2.9M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Hirofumi Imai: trading record in brief
All filings by Hirofumi Imai on record concern 富士製薬工業株式会社, in the capacity of chief executive. We count 7 filings; the first trade dates from 10 February 2023 and the latest from 31 July 2026.
On the market, this insider has only sold: 1 sale, €7.3M in total.
On 31 July 2026 came the latest disclosure, a transaction in 富士製薬工業株式会社. Filings reach the EDINET (Japan FSA) feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Hirofumi Imai
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ShareXTKSEDINET:S100YOUW
- 1.07% mcap18.4% of flowShareXTKSEDINET:S100YINT
- 1.10% mcap18.4% of flowShareXTKSEDINET:S100Y809
- 1.09% mcap18.3% of flowShareXTKSEDINET:S100Y1TH
- 46.0% of flowShareXTKSEDINET:S100TBRL
- 100.0% of flowShareXTKSEDINET:S100Q1CO
6 of 6 declarations
